Enveric Biosciences Inc vs iShares Semiconductor ETF — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while iShares Semiconductor ETF trades at $530.89. The key difference: iShares Semiconductor ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SOXX | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $655.01 |
52-Week Low | $1.28 | $236.93 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
The iShares Semiconductor ETF (SOXX) trades at $526.42, down 7.31% over 24 hours amid a broader semiconductor sector pullback. Technical indicators show a bearish trend with support at $511 and resistance at $554, while RSI levels near 37 suggest neutral momentum. The ETF has delivered exceptional year-to-date performance, rising 88.78% through mid-July 2026 according to Bank of America analysis, driven by AI demand and memory chip shortages.
Outlook remains tied to semiconductor cycle dynamics with AI growth as primary catalyst, though risks include sector volatility, crowded positioning noted by Bank of America, and high valuation sensitivity. Michael Burry's recent short position against the ETF highlights contrarian concerns about sustainability of the AI-driven rally.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →